Financhill
Sell
46

BHM Quote, Financials, Valuation and Earnings

Last price:
$11.30
Seasonality move :
-10.51%
Day range:
$10.37 - $11.58
52-week range:
$8.05 - $14.81
Dividend yield:
4.69%
P/E ratio:
--
P/S ratio:
0.65x
P/B ratio:
0.33x
Volume:
17.3K
Avg. volume:
7K
1-year change:
-19.59%
Market cap:
$43.3M
Revenue:
$50.2M
EPS (TTM):
-$2.90

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Bluerock Homes Trust, Inc. has 3.09% upside to fair value with a price target of $15.00 per share.

BHM vs. S&P 500

  • Over the past 5 trading days, Bluerock Homes Trust, Inc. has overperformed the S&P 500 by 15.1% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Bluerock Homes Trust, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Bluerock Homes Trust, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Bluerock Homes Trust, Inc. reported revenues of $16.6M.

Earnings Growth

  • Bluerock Homes Trust, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Bluerock Homes Trust, Inc. reported earnings per share of -$0.94.
Enterprise value:
789.3M
EV / Invested capital:
--
Price / LTM sales:
0.65x
EV / EBIT:
147.11x
EV / Revenue:
12.40x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
48.65x
Price / Operating cash flow:
2.57x
Enterprise value / EBITDA:
225.70x
Gross Profit (TTM):
-$10.9M
Return On Assets:
-3.16%
Net Income Margin (TTM):
-47.8%
Return On Equity:
-5.1%
Return On Invested Capital:
-3.24%
Operating Margin:
-36.89%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $40.3M $46.9M $63.6M $12.7M $16.6M
Gross Profit -$8M -$6.5M -$10.9M -$2.2M -$2.8M
Operating Income -$16.7M -$22.1M -$24.2M -$6.6M -$6.1M
EBITDA -$744K -$4.3M $3.5M -$1.7M $627K
Diluted EPS -$1.03 -$0.98 -$2.90 $0.24 -$0.94
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets -- $190.8M $95.6M $226.1M $195.1M
Total Assets -- $757.4M $670.7M $800.8M $1.1B
Current Liabilities -- $18.5M $15M $17.7M $11.8M
Total Liabilities -- $171.7M $181.6M $245.4M $452.7M
Total Equity -- $23.9M $489.1M $555.5M $640M
Total Debt -- $153.6M $167.1M $227.5M $420.7M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$2.1M $11.1M $33.3M $1.7M $13.4M
Cash From Investing -$17.9M -$44.7M -$235.6M $218K -$53.2M
Cash From Financing -$75.3M $102.7M $220.8M $39.3M $77.9M
Free Cash Flow -$11.6M $2.9M $16.2M -$601K $8.7M
BHM
Sector
Market Cap
$43.3M
$974.8M
Price % of 52-Week High
72.04%
86.99%
Dividend Yield
4.69%
2.45%
Shareholder Yield
-179.09%
3.12%
1-Year Price Total Return
-19.59%
--
Beta (5-Year)
--
0.628
Dividend yield:
4.69%
Annualized payout:
$0.00
Payout ratio:
44.13%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $10.26
200-day SMA
Sell
Level $11.33
Bollinger Bands (100)
Sell
Level 9.29 - 12.45
Chaikin Money Flow
Sell
Level -962.7K
20-day SMA
Buy
Level $9.48
Relative Strength Index (RSI14)
Buy
Level 58.68
ADX Line
Buy
Level 27.7
Williams %R
Neutral
Level -33.6709
50-day SMA
Buy
Level $9.51
MACD (12, 26)
Buy
Level 0.42
25-day Aroon Oscillator
Buy
Level 40
On Balance Volume
Sell
Level -414.2K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.3088)
Sell
CA Score (Annual)
Level (-1.7475)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (0.2639)
Buy
Piotroski F Score (Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Bluerock Homes Trust, Inc. engages in the provision of residential investments and other property-related income. It operates through the Scattered Single-Family Homes and Residential Communities segments. The Scattered Single-Family Homes segment includes the acquisition, ownership, management, and renovation of scattered single-family homes, which are, generally, detached homes with no onsite property management. The Residential Communities segment focuses on the acquisition, ownership, management, renovation, construction, and development of residential communities, which include both detached single-family home communities and attached unit communities such as apartments, townhouses, and duplexes. The company was founded on December 16, 2021 and is headquartered in New York, NY.

Stock Forecast FAQ

In the current month, BHM has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BHM average analyst price target in the past 3 months is $15.00.

  • Where Will Bluerock Homes Trust, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Bluerock Homes Trust, Inc. share price will rise to $15.00 per share over the next 12 months.

  • What Do Analysts Say About Bluerock Homes Trust, Inc.?

    Analysts are divided on their view about Bluerock Homes Trust, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bluerock Homes Trust, Inc. is a Sell and believe this share price will drop from its current level to $15.00.

  • What Is Bluerock Homes Trust, Inc.'s Price Target?

    The price target for Bluerock Homes Trust, Inc. over the next 1-year time period is forecast to be $15.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is BHM A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Bluerock Homes Trust, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of BHM?

    You can purchase shares of Bluerock Homes Trust, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bluerock Homes Trust, Inc. shares.

  • What Is The Bluerock Homes Trust, Inc. Share Price Today?

    Bluerock Homes Trust, Inc. was last trading at $11.30 per share. This represents the most recent stock quote for Bluerock Homes Trust, Inc.. Yesterday, Bluerock Homes Trust, Inc. closed at $10.67 per share.

  • How To Buy Bluerock Homes Trust, Inc. Stock Online?

    In order to purchase Bluerock Homes Trust, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.09% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.81% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 9.27% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock